Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02635399
Other study ID # 4-2015-0969
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 1, 2016
Est. completion date December 2019

Study information

Verified date March 2019
Source Yonsei University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Surgical resection in periampullary cancer using pancreaticoduodenectomy is the most important modality in the treatment. In the past, pancreaticoduodenectomy was associated with high morbidity and mortality. However, with the advances in techniques, including perioperative patient management, development of antibiotics, diagnostic radiology, and interventional treatments, pancreaticoduodenectomy is now considered a safe and feasible operation. Postoperative complication rates are reported to be in 10 to 20% in experienced hospitals and operation related mortality is at about 1%. Therefore, surgical treatment for periampullary cancer is actively considered.

However, postoperative complications, such as postoperative pancreatic fistula, (POPF) delayed gastric emptying, intraabdominal abscess, and postoperative bleeding, are still serious complications. Among these complications, delayed gastric emptying is considered less critical. However, delayed gastric emptying (DGE) can cause poor oral intake, which in turn, may lead to delay in recovery of postoperative nutritional state and in severe cases, requires insertion of levine tube and long-term fasting.

There have been many hypotheses for cause of DGE after pancreaticoduodenectomy, but definite cause have not been discovered yet. With the introduction of pylorus-preserving pancreaticoduodenectomy (PPPD), incidences of DGE were initially reported to have increased. However, results of most randomized comparative studies had concluded that PPPD and PD have no significance in occurence of DGE.

One hypothesis for cause of DGE we present here has to do with anatomic positioning of anastomosis site, especially pancreatojejunostomy (PJ) and duodenojejunostomy (DJ), after PPPD. Reconstruction after PPPD positions PJ and DJ close to each other. PJ site is often associated with one of postoperative complications, POPF. POPF may create inflammation around PJ site and pancreatitis, which may lead to severe adhesion around PJ as a secondary change. This adhesion and inflammation may cause DJ, which is located near PJ, to be pulled towards PJ site. When DJ is pulled towards PJ site, distal DJ site can become angulated and gastric contents may not beadle to pass easily. Gastric contents may be stagnated in stomach and thereby causing DGE. Therefore, in this study, we will fixate DJ on transverse colon using sutures, and prevent possibility of angulation of DJ. This additional procedure may reduce occurence of DGE.


Recruitment information / eligibility

Status Recruiting
Enrollment 78
Est. completion date December 2019
Est. primary completion date December 2019
Accepts healthy volunteers No
Gender All
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria:

- All periampullary pathologic conditions that require PPPD

- Age =20 and =80

- General performance status: the Karnofsky score> 70% or ECOG 0-1

Exclusion Criteria:

- Unresectable or locally advanced, metastatic case

- patients who do not want surgery

- ASA (American society of anesthesiologists' physical status classification) score: =3

- patients with drug or alcohol addiction

- patients showing low compliance

- patients who not want to involve the clinical trial

- patients who are unable to read or understand the informed consent, sign a consent form (eg, mental retardation, blindness, illiteracy, foreign, etc.)

- pylorus can not be preserved

- Patients undergoing laparoscopic PPPD

- Additional resection of adjacent organs or vascular resection was performed

- Previous history of open surgery

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
PPPD (pylorus-preserving pancreaticoduodenectomy)
pylorus-preserving pancreaticoduodenectomy is done in a conventional method. Additional DJ-pexy is performed for experimental group. DJ-pexy is performed by anchoring DJ site to transverse colon so that DJ is fixed to its original position.
PPPD (pylorus-preserving pancreaticoduodenectomy) with DJ-pexy
pylorus-preserving pancreaticoduodenectomy is done in a conventional method. Additional DJ-pexy is performed for experimental group. DJ-pexy is performed by anchoring DJ site to transverse colon so that DJ is fixed to its original position.

Locations

Country Name City State
Korea, Republic of Severance Hospital Seoul

Sponsors (1)

Lead Sponsor Collaborator
Yonsei University

Country where clinical trial is conducted

Korea, Republic of, 

References & Publications (1)

Khan AS, Hawkins WG, Linehan DC, Strasberg SM. A technique of gastrojejunostomy to reduce delayed gastric emptying after pancreatoduodenectomy. J Gastrointest Surg. 2011 Aug;15(8):1468-71. doi: 10.1007/s11605-011-1471-4. Epub 2011 Feb 24. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Occurence of clinically relevant DGE DGE is defined by International Study Group of Pancreatic Surgery consensus definition. Clinically relevant grade B or C will be recorded and occurrence rate of DGE between the arms will be compared. With the first 30days after surgery
Secondary Risk factors influencing DGE Preoperative, intraoperative, and postoperative variables will analyzed statistically between the arms Within the first 30 days after surgery
See also
  Status Clinical Trial Phase
Terminated NCT03757455 - ERAS Protocol in Pancreaticoduodenectomy and Total Pancreatectomy N/A
Recruiting NCT04118881 - Ear Acupuncture Preventing Delayed Gastric Emptying. N/A
Recruiting NCT06038734 - Using Point-of-Care-Ultrasound (POCUS) to Assess Gastric Contents Among Fasting Pre-operative Patients Taking GLP-1 Agonists.
Enrolling by invitation NCT02086461 - Pylorus Dysfunction After Esophagectomy and Gastric Tube Reconstruction. Effect of Pneumatic Pylorus Dilatation During Hospital Stay, Surgical Complications During in Hospital Stay N/A
Not yet recruiting NCT05314244 - Comparison Between Pylorus-resecting and Preserving Pancreaticoduodenectomy on Delayed Gastric Emptying and Nutrition N/A
Completed NCT02447237 - Randomized Trial:the Effect of Liquid Food on the Intake of Energy and Protein in Malignant Hematologic Patients N/A
Completed NCT06413888 - Nasogastric Decompression Following Pancreaticoduodenectomy N/A
Recruiting NCT05518643 - Compliance With ERAS Protocol in Pancreatic Surgery, Stress Response and Outcomes
Completed NCT03734627 - Gastrointestinal Nutrient Transit and Enteroendocrine Function After Upper Gastrointestinal Surgery
Recruiting NCT04418739 - Intravenous Human Albumin In Improving Pancreaticoduodenectomy Outcomes Phase 2
Active, not recruiting NCT05657327 - Application and Optimization of the International Study Group of Pancreatic Surgery (ISGPS) Definition and Grading Criteria for Postoperative Complications of Pancreatic Surgery in Laparoscopic Pancreatic Surgery
Completed NCT02397577 - Reference Values for Gastric Emptying N/A
Recruiting NCT05674643 - Gastric Assessment of Pediatric Patients Undergoing Surgery
Completed NCT03525067 - Colonization of Bile Ducts and Postoperative Infectious Complications of Pancreaticoduodenectomies
Terminated NCT01481753 - Pancreaticoduodenectomy With or Without Braun Enteroenterostomy: Comparison of Postoperative Pancreatic Fistula and Delayed Gastric Emptying N/A
Completed NCT03984734 - Quality of Life and Nutritional Status After Two Surgical Techniques in Pancreatoduodenectomy N/A
Withdrawn NCT02745028 - Monosodium Glutamate on Gastric Emptying N/A
Completed NCT00845858 - Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Patients With Gastroparesis Phase 2
Recruiting NCT05709197 - The Effectiveness of Adding Braun Anastomosis to Standard Child Reconstruction After Pancreatoduodenectomy N/A
Completed NCT03512145 - Clinical Evaluation of the VIPUN Balloon Catheter 0.2 in Critically Ill Patients N/A